Revealed: This Pot Stock Could Soon Pay a Dividend

Aphria’s (TSX:APHA)(NYSE:APHA) CFO just confirmed it. The company could be the first pot producer to pay a regular dividend.

Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

One of the biggest stories in Canadian business over the latter half of 2019 was the massive implosion of Canada’s marijuana sector. Leading pot stocks fell as much as 50-75%.

A number of factors contributed to the fall, but mostly it came down to sentiment. Investors went from being incredibly bullish on the future of legal marijuana in Canada to realizing there was way too much supply in the system, all within the span of a few months. We’re now in a period of reckoning, which will undoubtedly end with some of the weaker producers going bankrupt.

Amid all this carnage could be an interesting buying opportunity. The legal pot market should continue to grow, as more kinks get ironed out of the system and as marijuana edibles become more popular. Many smokers still have their dealer on speed dial — something that should begin to change as more stores open with more consistent supply. And some of the top marijuana producers are finally starting to get serious about profitability, which is always a good thing for investors.

One pot stock is even considering a pretty major step — something that will immediately make it leap onto certain investors’ radars.

Dividend-paying marijuana?

Aphria (TSX:APHA)(NYSE:APHA) recently released its quarterly numbers, and the stock sold off some 8% on the news.

Investors were disappointed in top-line results. Revenue was expected to be $130 million, but actual numbers came up short, with the company only posting $121 million in sales. The company also cut its full-year revenue forecast, slashing sales estimates from $650 to $700 million to a range of $575 to $625 million.

It wasn’t all bad news, however. The company reported a tiny $1.9 million adjusted EBITDA profit in its most recent quarter and projected the adjusted EBITDA would be between $35 and $42 million for the year. In a world filled with marijuana companies that will still struggle for any sort of profitability in 2020, Aphria stands as a rare beacon of strength.

Aphria also has a strong balance sheet with nearly $400 million in cash. It’s well positioned to gobble up any prime assets from any struggling marijuana producers. And with serious profitability just around the corner, the company is even looking at sending money back to shareholders.

During the conference call discussing this quarter’s earnings with analysts, Aphria’s CFO told investors the company was strongly considering paying the sector’s first consistent dividend.

As part of his remarks, CFO Carl Merton told investors the company looks forward to “in the future being in the position to provide an annual return to our shareholders through dividends.”

Merton and the rest of Aphria’s management team didn’t mention a specific date, but I think the company could institute a regular dividend by the end of 2020, depending on whether it can deliver on its profitability goals.

Paying a regular dividend could give Aphria one major advantage over its peers. There are hundreds of Canadian mutual funds and exchange-traded funds that insist on only investing in stocks that pay a dividend. These funds are likely to have big interest in adding a fast-growing marijuana producer to their portfolios. They’re just waiting for such a company to become profitable enough a regular dividend is a possibility.

The bottom line

Although Aphria shares are reeling after cutting guidance, this dividend chatter is good news. It shows management is confident in the future and that the company is serious about profitability. The best returns going forward will come from pot producers who can show they can make consistent profits. Aphria isn’t quite there yet, but I like the direction it’s heading.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »